Novo Nordisk's pricing approaches inside the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who may have accused the company of selling price gouging, pointing out the stark contrast concerning U.S. prices and those in Europe and copyright. But Rybelsus and copyright